Uthorization Of Bamlanivimab With English-only Labels For Use In Relation To The Covid-19 Pandemic

Summary Health Canada authorized the use of bamlanivimab, a monoclonal antibody treatment for COVID-19, with labels provided only in English. This authorization was granted as part of pandemic response measures to allow faster distribution of the treatment across Canada.

Reason

COVID - Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-12-18

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/16f74d66-e4f6-40fa-a374-6df69dc3d769